January 2016

Scientists identify new amino acid transporter in the kidney with potential impact on cystinuria

Research groups led by Dr. Virginia Nunes and Dr. Manuel Palacin, UB professors and researchers from Bellvitge Biomedical Research Institute (IDIBELL) and Institute for Research in Biomedicine Barcelona (IRB Barcelona), respectively, at the same time responsible for the Ciber 730 and U731 units for Rare Diseases (CIBERER), have identified the AGT1/rBAT protein as a new

Scientists identify new amino acid transporter in the kidney with potential impact on cystinuria Read More »

Cancer stem cell regulation changes during skin carcinoma progression to promote metastasis

Researchers from the group of Aging and Cancer, led by Purificación Muñoz in the Institute of Biomedical Research of Bellvitge (IDIBELL) demonstrated that the cancer stem cell features change during the skin squamous cell carcinoma progression to generate highly aggressive and metastasis prone tumors. These results were recently published in Cancer Research journal. Squamous cell

Cancer stem cell regulation changes during skin carcinoma progression to promote metastasis Read More »

Genetic engineering to prevent rejection in xenotransplantation

The major limitation involving the transplantation of cells, tissues and organs of animal origin (xenotransplantation, mostly of the pig) in humans is rejection due to the activation of various immune system mechanisms. Overcoming this limitation requires great efforts in xenotransplantation research, such as that led IDIBELL researcher Cristina Costa, who has devoted most of his

Genetic engineering to prevent rejection in xenotransplantation Read More »

Scroll to Top